Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Alberta
Burn patients being followed and treated in the Outpatient Burn Clinic with large areas of HTS are approached to participate in the study. Patients who agree to participate and who have signed an informed consent are entered into the trial.
Pre-treatment evaluation and monthly examinations include:
* standardized photographs of scar
* scar volume
* Vancouver Burn Scar Assessment (VBSA)
* blood work (TGF-beta, histamine)
* urine collection (histamine)
* 6mm punch biopsy of HTS and adjacent normal skin (every two months)
Patients are randomized to received with placebo or Intron A 1x106 IU a day for 7 days, then 3x106 IU 3 SC, three times a week for 23 weeks.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
burns \> 5% tbsa
informed consent
no prior exposure to interferon or other cytokines